This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stocks in Motion

For 2005, Henry Schein forecast earnings of $1.75 to $1.77 a share. Analysts had expected earnings of $1.85 a share. Shares recently fell $1.19 to $40.82.

Sepracor (SEPR) rose 4% after the pharmaceutical company reported a narrower-than-expected third-quarter loss on a sharp rise in sales. The company posted a loss of $2.2 million, or 2 cents a share, compared with $130.4 million, or $1.40 a share, a year earlier. Results included a one-time gain of $18.3 million, or 17 cents a share. Analysts were expecting a loss of 60 cents a share. Sales jumped to $205.7 million from $80.1 million, well above analysts' forecast of $166 million. Sepracor shares were trading up $2.44 to $56.86.

Shares of Nature's Sunshine (NATR - Get Report) fell 8% after the vitamin maker posted third-quarter earnings that fell short of forecasts. The company earned $4.3 million, or 28 cents a share, missing analysts' expectation of 34 cents a share. Sales, which came in at $87.7 million, were slightly shy of Wall Street's prediction of $87.4 million. A year earlier, the company earned $4.6 million, or 29 cents a share, on sales of $84.5 million.

Sales at the company's Synergy Worldwide unit declined 16% to $20.4 million, contributing to the weaker-than-expected results. Nature's Sunshine sales in the U.S. grew 10.5% to $37.3 million. Shares were down $1.73 to $18.87.

Other health care volume movers included Pfizer (PFE - Get Report), up 4 cents to $21.13; Novavax (NVAX - Get Report), up 48 cents to $4.63; Amgen (AMGN - Get Report), up 31 cents to $75.62; Johnson & Johnson (JNJ - Get Report), down 63 cents to $63.47; Merck (MRK), down 14 cents to $26.86; Bristol-Myers Squibb (BMY), up 14 cents to $21.78; and BioCryst Pharmaceuticals (BCRX), up 16 cents to $15.39.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
LCAV $5.37 0.00%
AMGN $163.52 0.00%
HSIC $156.63 0.00%
JNJ $102.37 0.00%
NATR $12.27 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs